XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 42,280,618 $ 50,999,442
Prepaid expenses and other current assets 984,860 174,938
Total current assets 43,265,478 51,174,380
Goodwill 9,600,240 9,600,240
In-process research and development 4,800,000 4,800,000
Property and equipment, net 30,813 45,800
Right-of-use asset 403,894 575,406
Other non-current assets 18,996 74,151
Total assets 58,119,421 66,269,977
Current liabilities:    
Accounts payable 708,203 1,003,937
Accrued liabilities and other current liabilities 1,686,739 2,059,238
Operating lease liability 201,976 215,926
Total current liabilities 2,596,918 3,279,101
Deferred tax liability 201,792 201,792
Other non-current liabilities 255,150 410,660
Total liabilities 3,053,860 3,891,553
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized at September 30, 2024 and December 31, 2023; 49,046,246 and 49,046,246 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 49,046 49,046
Additional paid-in capital 479,076,908 478,149,161
Accumulated other comprehensive loss (123,803) (118,090)
Accumulated deficit (423,936,590) (415,701,693)
Total stockholders’ equity 55,065,561 62,378,424
Total liabilities and stockholders' equity $ 58,119,421 $ 66,269,977